Escalon Medical Total Non-Operating Income/Expense 2010-2025 | ESMC

Escalon Medical total non-operating income/expense from 2010 to 2025. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
Escalon Medical Annual Total Non-Operating Income/Expense
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $1
2019 $0
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $0
2010 $-1
2009 $0
Escalon Medical Quarterly Total Non-Operating Income/Expense
(Millions of US $)
2025-03-31 $0
2024-12-31 $0
2024-09-30 $0
2024-06-30 $0
2024-03-31 $0
2023-12-31 $0
2023-09-30 $0
2023-06-30 $0
2023-03-31 $0
2022-12-31 $0
2022-09-30 $0
2022-06-30 $0
2022-03-31 $0
2021-12-31 $0
2021-09-30 $1
2021-06-30 $0
2021-03-31 $0
2020-12-31 $0
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
2019-12-31 $0
2019-09-30 $1
2019-06-30 $0
2019-03-31 $0
2018-12-31 $0
2018-09-30 $0
2018-06-30 $0
2018-03-31 $0
2017-12-31 $0
2017-09-30 $0
2017-06-30 $0
2017-03-31 $0
2016-12-31 $0
2016-09-30 $0
2016-06-30 $0
2016-03-31 $0
2015-12-31 $0
2015-09-30 $0
2015-06-30 $0
2015-03-31 $0
2014-12-31 $0
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $0
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31 $0
2012-09-30 $0
2012-06-30 $0
2012-03-31 $0
2011-12-31 $0
2011-09-30 $0
2011-06-30 $0
2011-03-31 $0
2010-12-31 $0
2010-09-30 $0
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.003B $0.012B
Escalon Medical Corp. develops, markets and distributes ophthalmic diagnostic, surgical and pharmaceutical products as well as vascular access devices. The company utilizes strategic partnerships to help finance its development programs and is also seeking acquisitions to further diversify its product line to achieve critical mass in sales and take better advantage of the company's distribution capabilities.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.604B 21.88
Becton Dickinson (BDX) United States $50.274B 12.45
Cardinal Health (CAH) United States $36.816B 19.28
Straumann Holding AG (SAUHY) Switzerland $21.909B 0.00
Labcorp (LH) United States $20.885B 16.94
Cooper (COO) United States $16.582B 21.99
West Pharmaceutical Services (WST) United States $15.565B 32.63
Align Technology (ALGN) United States $13.648B 27.09
Henry Schein (HSIC) United States $8.770B 15.04
Merit Medical Systems (MMSI) United States $5.841B 28.24
DENTSPLY SIRONA (XRAY) United States $3.328B 9.94
CONMED (CNMD) United States $1.865B 13.96
STAAR Surgical (STAA) United States $0.952B 0.00
Lifevantage (LFVN) United States $0.169B 17.39
Pro-Dex (PDEX) United States $0.141B 15.40